In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary


tropomysin receptor kinase inhibitor AZD7451 
A tropomyosin receptor kinase (TRK) inhibitor with potential antineoplastic activity. AZD7451 binds to TRK, thereby preventing the neurotrophin-TRK interaction and subsequent TRK activation. This may eventually result in an inhibition of tumor cell proliferation in TRK-expressing tumor cells. TRK, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth, invasion and survival. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:TRK Inhibitor AZD7451
Code name:AZD7451
Back to TopBack to Top